Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Levodopa Inhalation Powder: A Review in Parkinson’s Disease
Julia Paik
Drugs (2020) Vol. 80, Iss. 8, pp. 821-828
Closed Access | Times Cited: 17

Showing 17 citing articles:

Inhaled Medicines: Past, Present, and Future
Sandra D. Anderson, Paul J. Atkins, Per Bäckman, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 48-118
Open Access | Times Cited: 78
The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?
Yuqing Ye, Ying Ma, Jesse Zhu
International Journal of Pharmaceutics (2022) Vol. 614, pp. 121457-121457
Open Access | Times Cited: 76
Enhanced Delivery of Neuroactive Drugs via Nasal Delivery with a Self‐Healing Supramolecular Gel
Julie Tzu Wen Wang, Ana C. Rodrigo, Anna K. Patterson, et al.
Advanced Science (2021) Vol. 8, Iss. 14
Open Access | Times Cited: 53
Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol
Rahul Rahul, Yasir Hasan Siddique
CNS & Neurological Disorders - Drug Targets (2021) Vol. 20, Iss. 4, pp. 327-342
Closed Access | Times Cited: 51
Improving the Delivery of Levodopa in Parkinson’s Disease: A Review of Approved and Emerging Therapies
Daniele Urso, К. Ray Chaudhuri, Mubasher A. Qamar, et al.
CNS Drugs (2020) Vol. 34, Iss. 11, pp. 1149-1163
Closed Access | Times Cited: 38
Pharmaceutical dry powders of small molecules prepared by thin-film freezing and their applications – A focus on the physical and aerosol properties of the powders
Tuangrat Praphawatvet, Zhengrong Cui, Robert O. Williams
International Journal of Pharmaceutics (2022) Vol. 629, pp. 122357-122357
Closed Access | Times Cited: 16
Recent advances in electrochemical C–H bond amination
Chen Liu, Ji‐Xuan Liu, Wenyi Li, et al.
Organic Chemistry Frontiers (2023) Vol. 10, Iss. 20, pp. 5309-5330
Closed Access | Times Cited: 10
Recent progress in the intranasal PLGA-based drug delivery for neurodegenerative diseases treatment.
Nasim Aghaei Delche, Reyhaneh Kheiri, Behnam Ghorbani Nejad, et al.
PubMed (2023) Vol. 26, Iss. 10, pp. 1107-1119
Closed Access | Times Cited: 7
Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations
Amr Hassan, Dale Farkas, P. Worth Longest, et al.
International Journal of Pharmaceutics (2020) Vol. 591, pp. 120027-120027
Open Access | Times Cited: 20
Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics
Ramón Cacabelos, Iván Carrera, Olaia Martínez, et al.
Medicinal Research Reviews (2021) Vol. 41, Iss. 5, pp. 2841-2886
Closed Access | Times Cited: 12
Engineering of levodopa inhalable microparticles in combination with leucine and dipalmitoylphosphatidylcholine by spray drying technique
Sara Bahrainian, Maryam Sadat Mirmoeini, Zahra Gilani, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 167, pp. 106008-106008
Closed Access | Times Cited: 9
Micro-fluidic Spray Freeze Dried Ciprofloxacin Hydrochloride-Embedded Dry Powder for Inhalation
Yingjie Chen, Shen Yan, Shengyu Zhang, et al.
AAPS PharmSciTech (2022) Vol. 23, Iss. 6
Closed Access | Times Cited: 6
Cell-based in vitro models for pulmonary permeability studies
Clémentine Richter, Tobias Neu, Lorenz Latta, et al.
Elsevier eBooks (2024), pp. 137-168
Closed Access
Applications of Spray-Dried Vaccines
Cordin Arpagaus
Springer eBooks (2023), pp. 325-530
Closed Access | Times Cited: 1
Update on Parkinson's Disease Therapy
Rebecca M. Gilbert
touchREVIEWS in Neurology (2021) Vol. 17, Iss. 2, pp. 92-92
Open Access | Times Cited: 2
Development of Levodopa-loaded inhalable dry powders for treatment of Parkinson's disease via the pulmonary system
Mahasweta Paul
(2022)
Open Access
High-dose versus low-dose inhaled levodopa (CVT-301) in patients with Parkinson disease for the treatment of OFF episodes: a meta-analysis of randomized controlled trials
Zeya Yan, Wei Wang, Xinyu Tao, et al.
Neurological Sciences (2022) Vol. 43, Iss. 11, pp. 6233-6241
Closed Access
Page 1

Scroll to top